Healthmed Services Ltd. (HEME.OB) formed in 2000 when technology was on the rise. The focus of the company has been to develop products to better efforts of the healthcare industry through the use of technology. The company works on a revolutionary product that will forever change the way the healthcare industry communicates within itself.
**HealthMed Services to Acquire Neural Communicator
Today HEME, an innovative software development company, is pleased to announce that it has entered final negotiations to acquire all rights, title and interest to Neural Communicator software and hardware.
Neural Communicator has developed brain/computer interface devices and software designed to enable people with extreme disabilities to communicate. The device detects eye movement, jaw contractions and ALPHA and BETA brain waves allowing hands free input.
Neural Communicator is intended for people disabled in such a way that they cannot communicate by speech or by using their body. Biofeedback is used for computer input and controlling the application features.
The developers of the software and hardware will continue to work with HealthMed on an outsourcing basis in developing further applications for the Neural Communicator.
For more information about this company please visit http://www.healthmedltd.com
Medtronic, Inc. (NYSE:MDT) is the global leader in medical technology - alleviating pain, restoring health, and extending life for millions of people around the world.
**Medtronic Receives Health Canada Approval for the Newest Radiofrequency Ablation Tools for Atrial Fibrillation
The company MDT recently announced it received Health Canada approval for the Medtronic Ablation Frontiers Cardiac Ablation System, a novel radiofrequency (RF) ablation technology for the treatment of atrial fibrillation (AF).
AF is the most common heart arrhythmia that affects more than 250,000 Canadians and seven million people worldwide.
The Medtronic Ablation Frontiers Cardiac Ablation System tools now approved for use in Canada include the GENius(TM) Multi-Channel Radiofrequency Generator and the Pulmonary Vein Ablation Catheter (PVAC)(TM), a single anatomically shaped mapping and ablation catheter designed to efficiently isolate the pulmonary veins to treat AF.
The GENius generator and PVAC, with the addition of the Multi-Array Septal Catheter (MASC)(TM) and Multi-Array Ablation Catheter (MAAC)(TM), are available in Europe and are under investigational use in the United States.
Medtronic will provide periodic clinical updates on the safety and effectiveness of the PVAC catheter as a condition of Health Canada’s approval.
For more information about this company please visit http://www.medtronic.com
Varian Medical Systems, Inc. (NYSE:VAR) is the world’s leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy.
The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices.
Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection.
Varian Medical Systems employs approximately 5,200 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world.
**Varian Medical Systems Establishes Radiotherapy Training Center in Mumbai, India
The company VAR recently has established its first education center in India to train medical physicists and technologists working on the company’s advanced cancer treatment systems.
The center in Mumbai, equipped with 16 planning system workstations and the VERT training system for radiotherapy treatment simulations, will enable the country’s growing number of radiotherapists and medical physicists to train without having to travel overseas.
The official opening, which was attended by Kanta Chokkra, president of the Association of Medical Physicists of India, was carried out by Kolleen Kennedy, Varian’s VP Customer Support Services.
For more information about this company please visit http://www.varian.com
CRWESelect, a stock highlight publication is pleased to alert investors of stocks on the move.
Sign Up for our Free Stock Newsletter at http://www.crweselect.com/signup
PLEASE BE SURE TO VISIT CRWESELECT.NING.COM
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received five thousand dollars in cash from a third party (Media Elite Consultants LLC) for (1) day of advertising for Healthmed Services Ltd. (OTC BB: HEME.OB)
HEMEcrweselect0902
